Países
La atención médica trata las enfermedades. El cuidado de la vida consiste en proteger la salud, todos los días, durante toda la vida.
Healthcare today fails millions because early, continuous, and non-invasive signals for timely risk triage are missing. As a result, complications from diabetes, cardiovascular disease, kidney disorders, and other systemic conditions are detected too late.
Remidio harnesses AI-powered imaging and foundational vision models to use the eye as a scalable access point for holistic health monitoring making proactive, preventive care affordable, mobile, and accessible across India, Southeast Asia, Africa, underserved regions in the US, and beyond.
Every eye exam now has the power to protect both sight and life.
.jpg)
Oculomics represents a fundamental shift in healthcare from reacting to disease, to predicting and preventing it.
The retina is the most information-dense, non-invasive health sensor in the human body. Remidio’s pioneering oculomics platform transforms routine eye exams into powerful life-care signals enabling early, predictive, and population-scale health screening.
Routine eye scans, powered by Remidio’s Vision Foundational Models and simple-to-use imaging devices, converge with broader health monitoring blurring the boundaries between ophthalmology, optometry, and primary care so systemic diseases can be tracked non-invasively.
No longer limited to privileged health systems, oculomics is now a practical pathway to early detection of diabetes, cardiovascular risk, chronic kidney disease, liver disease, anaemia, pulmonary embolism, pre-eclampsia, neurodegeneration, and even biological aging from a single eye exam.
Remidio’s patented, smartphone-enabled imaging devices deliver high-quality retinal images in any setting urban clinics, rural outreach programs, public health centres, or even patients’ homes.
With On-the-Edge AI, all analysis and reporting happen instantly and offline, with no dependence on cloud GPUs or connectivity ensuring patient privacy and rapid results.
Our evolving AI portfolio extends beyond blinding eye diseases such as DR, AMD, and Glaucoma to systemic disease risk triaging including CVD, CKD, liver fibrosis, anaemia, and pre-eclampsia deployable with minimal training in non-specialist settings.
This bridges specialty medicine and primary care, enabling health systems to shift from episodic care to continuous risk intelligence, while making health screening accessible and convenient for patient.
Certificaciones:
Oculomics for the Next Billion funciona en todos los silos de atención, lo que permite a los equipos de atención primaria, optometría y oftalmología colaborar en la detección predictiva, la clasificación temprana y la simplificación de las derivaciones.
Los exámenes oculares de rutina ahora forman parte de los exámenes de salud generales, lo que ayuda a los proveedores a actuar antes y a prevenir complicaciones costosas en etapas avanzadas.
La plataforma multimodal de Remidio captura biomarcadores críticos de la retina, el nervio óptico y la parte anterior del ojo, y detecta múltiples enfermedades en solo unos minutos. Nuestra hoja de ruta incluye un despliegue ligero y validado para la anemia, la fibrosis hepática, la embolia pulmonar y más.
.webp)
La visión oculómica de Remidio es llevar la salud predictiva y preventiva a las poblaciones que más la necesitan.
Nuestra plataforma móvil, asequible y validada localmente se está adoptando en programas de salud nacionales, misiones gubernamentales y proyectos piloto público-privados en más de 40 países.
Las exploraciones oculares de rutina ahora pueden formar parte de los exámenes de salud generales, y Remidio está creando el foso de datos y las asociaciones para lograr esta escala.
Únase al movimiento de Remidio para hacer que la salud proactiva y predictiva sea posible para todos, donde cada examen ocular es una puerta de entrada para salvar la vista y la vida.